Form 4: Aurinia Pharmaceuticals Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Chief Medical Officer Greg Keenan sold 8,305 shares of Aurinia Pharmaceuticals Inc. to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 7, 2025, Greg Keenan, Chief Medical Officer of Aurinia Pharmaceuticals Inc., sold 8,305 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on March 6, 2023.
- The shares were sold at a weighted average price of $8.23, with individual transactions ranging from $8.20 to $8.25.
- Following the transaction, Keenan directly owns 153,484 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and does not contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares by company executives are a normal part of equity compensation and personal financial management. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor, temporary impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of restricted stock unit grant related to the tax obligation. |
| 03/07/2025 | Date of stock sale to cover tax withholding obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.